# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-007788
Filing Date
2018-11-08
Accepted
2018-11-08 15:15:34
Documents
79
Period of Report
2018-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | f10q_110818p.htm | 10-Q | 591113
2 | EXHIBIT 10.1 | exh_101.htm | EX-10.1 | 6657
3 | EXHIBIT 10.2 | exh_102.htm | EX-10.2 | 15665
4 | EXHIBIT 10.3 | exh_103.htm | EX-10.3 | 2450
5 | EXHIBIT 10.5 | exh_105.htm | EX-10.5 | 822334
6 | EXHIBIT 31.1 | exh_311.htm | EX-31.1 | 9056
7 | EXHIBIT 31.2 | exh_312.htm | EX-31.2 | 9349
8 | EXHIBIT 32.1 | exh_321.htm | EX-32.1 | 3779
9 | EXHIBIT 32.2 | exh_322.htm | EX-32.2 | 3771
16 | GRAPHIC | exh101_01.jpg | GRAPHIC | 259513
17 | GRAPHIC | exh101_02.jpg | GRAPHIC | 109810
18 | GRAPHIC | exh103_01.jpg | GRAPHIC | 287586
19 | GRAPHIC | exh103_02.jpg | GRAPHIC | 121670
20 | GRAPHIC | exh102_01.jpg | GRAPHIC | 298284
21 | GRAPHIC | exh102_02.jpg | GRAPHIC | 262598
22 | GRAPHIC | exh102_03.jpg | GRAPHIC | 150172
23 | GRAPHIC | exh102_04.jpg | GRAPHIC | 341310
24 | GRAPHIC | exh102_05.jpg | GRAPHIC | 262991
25 | GRAPHIC | exh102_06.jpg | GRAPHIC | 247574
26 | GRAPHIC | exh102_07.jpg | GRAPHIC | 302191
27 | GRAPHIC | exh102_08.jpg | GRAPHIC | 256158
28 | GRAPHIC | exh102_09.jpg | GRAPHIC | 215070
29 | GRAPHIC | exh102_10.jpg | GRAPHIC | 288844
30 | GRAPHIC | exh102_11.jpg | GRAPHIC | 264268
31 | GRAPHIC | exh102_12.jpg | GRAPHIC | 207625
32 | GRAPHIC | exh102_13.jpg | GRAPHIC | 200384
33 | GRAPHIC | exh102_14.jpg | GRAPHIC | 267323
34 | GRAPHIC | exh102_15.jpg | GRAPHIC | 290463
35 | GRAPHIC | exh102_16.jpg | GRAPHIC | 217382
36 | GRAPHIC | exh102_17.jpg | GRAPHIC | 227743
37 | GRAPHIC | exh102_18.jpg | GRAPHIC | 242018
38 | GRAPHIC | exh102_19.jpg | GRAPHIC | 144530
39 | GRAPHIC | exh102_20.jpg | GRAPHIC | 252959
40 | GRAPHIC | exh102_21.jpg | GRAPHIC | 194485
41 | GRAPHIC | exh102_22.jpg | GRAPHIC | 292232
42 | GRAPHIC | exh102_23.jpg | GRAPHIC | 304874
43 | GRAPHIC | exh102_24.jpg | GRAPHIC | 324502
44 | GRAPHIC | exh102_25.jpg | GRAPHIC | 273961
45 | GRAPHIC | exh102_26.jpg | GRAPHIC | 142380
| Complete submission text file | 0001171843-18-007788.txt |  | 15062006

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL INSTANCE FILE | bcrx-20180930.xml | EX-101.INS | 863153
11 | XBRL SCHEMA FILE | bcrx-20180930.xsd | EX-101.SCH | 47386
12 | XBRL CALCULATION FILE | bcrx-20180930_cal.xml | EX-101.CAL | 35895
13 | XBRL DEFINITION FILE | bcrx-20180930_def.xml | EX-101.DEF | 335108
14 | XBRL LABEL FILE | bcrx-20180930_lab.xml | EX-101.LAB | 326023
15 | XBRL PRESENTATION FILE | bcrx-20180930_pre.xml | EX-101.PRE | 344076

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 181169434
SIC: 2836 Biological Products, (No Diagnostic Substances)